Skip to main content

Table 1 People with epilepsy and annual in-part requirement of PB across different divisions of Bhutan

From: Availability and sufficiency of phenobarbital, an essential medication, in Bhutan: a survey of global and neuropsychiatric relevance

Province

Population

PEP

Target pop

PB requirement/year (Kg)

3 Km (%)

P/D

Bumthang

18,965

114

11

0.5

75

7715

Chhukha

88,342

530

53

2.1

NA

4908

Dagana

27,522

165

16

0.7

NA

NA

Gasa

3,694

22

2

0.1

NA

3694

Haa

13,499

81

8

0.3

71

1227

Lhuentse

17,618

106

11

0.4

87

17,201

Monggar

44,259

266

27

1.1

89

2168

Paro

43,167

259

26

1.0

NA

10,415

Pemagatshel

25,176

151

15

0.6

68

8394

Punakha

17,715

106

11

0.4

NA

NA

Samdrupjonkhar

39,961

240

24

1.0

NA

NA

Samtse

60,100

361

36

1.4

NA

NA

Sarpang

45,637

274

27

1.1

93

2985

Thimphu

98,676

592

59

2.4

94

1015

Trashigang

56,168

337

34

1.4

NA

9361

Trashiyangtse

20,874

125

12

0.5

72

5139

Trongsa

13,419

81

8

0.3

NA

NA

Tsirang

18,667

112

11

0.4

NA

NA

Wangdue

36,922

222

22

0.9

NA

NA

Zhemgang

18,636

112

11

0.4

NA

NA

  1. Annual requirement of PB100 mg tablets is based on prevalent lifetime epilepsy pool of patients. Target population was defined as treating 50.0% of the 20.0% of the prevalent epilepsy population (i.e. column 4)
  2. 3Km proportion of population within 3 Km walking distance, NA no information available, PEP prevalent epilepsy population, PB phenobarbital, P/D number of persons per doctor